Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
45.1M
-
Number of holders
-
84
-
Total 13F shares, excl. options
-
44M
-
Shares change
-
+3.75M
-
Total reported value, excl. options
-
$597M
-
Value change
-
+$51M
-
Number of buys
-
48
-
Number of sells
-
-23
-
Price
-
$13.55
Significant Holders of Third Harmonic Bio, Inc. - Common Stock, par value $0.0001 per share (THRD) as of Q3 2024
90 filings reported holding THRD - Third Harmonic Bio, Inc. - Common Stock, par value $0.0001 per share as of Q3 2024.
Third Harmonic Bio, Inc. - Common Stock, par value $0.0001 per share (THRD) has 84 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 44M shares
of 45.1M outstanding shares and own 97.68% of the company stock.
Largest 10 shareholders include Atlas Venture Life Science Advisors, LLC (10.9M shares), ORBIMED ADVISORS LLC (5.78M shares), BVF INC/IL (4.37M shares), EcoR1 Capital, LLC (3.18M shares), GENERAL ATLANTIC, L.P. (2.96M shares), T. Rowe Price Investment Management, Inc. (2.83M shares), TCG Crossover Management, LLC (2.42M shares), Boxer Capital, LLC (2M shares), BlackRock, Inc. (1.46M shares), and COMMODORE CAPITAL LP (1.36M shares).
This table shows the top 84 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.